Global Cell Lysis/Cell Fractionation Market Size, Share, and Trends - Forecast 2026-2032 | AI, Automation, and Multi-Omics Drive 8.82% CAGR and a USD 7.14 Billion Opportunity by 2032
Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Cell Lysis/Cell Fractionation Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.
The global cell lysis and cell fractionation market research report provides strategic intelligence on technologies, applications, regional demand, competitive priorities, and emerging workflow requirements. The market is projected to reach USD 4.29 billion in 2026 and expand at a CAGR of 8.82% to USD 7.14 billion by 2032, supported by growth in cell-based research, multi-omics, biologics manufacturing, diagnostics, vaccine development, and regenerative medicine.
Market Scope and Growth Drivers
Cell lysis and fractionation enable access to intracellular proteins, nucleic acids, organelles, membranes, metabolites, and other subcellular structures. These foundational workflows serve molecular biology, genomics, proteomics, cell biology, biopharmaceutical production, and quality control.
Market demand is being strengthened by single-cell analysis, viral vector development, recombinant protein production, and the need for reproducible sample preparation. The analysis supports strategic planning by clarifying where workflow innovation, laboratory modernization, and expanding biomanufacturing capacity are creating commercial opportunities.
Technology and Workflow Landscape
Laboratories are shifting from manual, protocol-dependent procedures toward automated, standardized, and application-specific platforms. Closed and semi-closed systems are gaining attention for reducing contamination, improving operator safety, and supporting regulated environments.
Transformative Market Shifts
Demand is moving toward gentler, more selective methods that preserve mitochondria, nuclei, exosomes, membrane proteins, enzymes, and other sensitive targets. Optimized buffer chemistries, controlled homogenization, microfluidic disruption, and reproducible centrifugation are becoming increasingly important.
Multi-omics research is also driving protocols capable of recovering proteins, RNA, DNA, lipids, and metabolites from limited or heterogeneous samples. Sustainability considerations-including reduced hazardous reagents, fewer processing steps, lower plastic use, and simplified storage-are influencing procurement decisions.
Artificial Intelligence and Automation
Artificial intelligence is improving protocol optimization, experimental design, quality control, and workflow predictability. AI-enabled systems can evaluate sample characteristics, buffer composition, instrument settings, and downstream results to identify conditions that enhance yield, purity, and reproducibility.
Machine learning can also support adaptive control of homogenizers, sonicators, centrifuges, and microfluidic platforms by monitoring temperature, pressure, viscosity, turbidity, and particle distribution. These insights give decision-makers a clearer basis for prioritizing automation investments, mitigating process risk, and differentiating solutions in high-throughput or regulated settings.
Regional and Economic Group Insights
ASEAN and BRICS markets favor scalable, affordable, and locally supported systems, while the European Union and G7 emphasize automation, data integrity, and compliance. GCC investment in genomics and research hospitals is creating opportunities in precision medicine, while NATO countries place additional value on biosecurity and resilient laboratory infrastructure. These distinctions inform market entry strategies, partnership planning, and product positioning.
Strategic Priorities for Industry Participants
Key Takeaways from This Report
Key Attributes:
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell Lysis/Cell Fractionation Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Bead Mills
7.2.2. French Press Systems
7.2.3. Homogenizers
7.2.4. Sonicators
7.3. Kits & Reagents
7.3.1. Buffer Kits
7.3.2. Detergents
7.3.3. Disruption Kits
7.3.4. Protease Inhibitors
8. Cell Lysis/Cell Fractionation Market, by Technology
8.1. Introduction
8.2. Chemical Lysis
8.2.1. Detergent Based Lysis
8.2.2. Solvent Based Lysis
8.3. Enzymatic Digestion
8.3.1. Lysozyme Digestion
8.3.2. Protease Digestion
8.4. Mechanical Disruption
8.4.1. Bead Milling
8.4.2. High-Pressure Homogenization
8.4.3. Sonication
8.5. Thermal Lysis
9. Cell Lysis/Cell Fractionation Market, by Cell Type
9.1. Introduction
9.2. Mammalian Cells
9.3. Bacterial Cells
9.4. Yeast Cells
9.5. Plant Cells
9.6. Insect Cells
10. Cell Lysis/Cell Fractionation Market, by Application
10.1. Introduction
10.2. Cell Biology
10.2.1. Flow Cytometry
10.2.2. Western Blotting
10.3. Drug Discovery
10.3.1. Assay Development
10.3.2. HTS
10.4. Genomics
10.4.1. DNA Extraction
10.4.2. RNA Extraction
10.5. Metabolomics
10.5.1. GC-MS
10.5.2. NMR
10.6. Proteomics
10.6.1. 2D Electrophoresis
10.6.2. LC-MS
10.7. Protein Extraction
11. Cell Lysis/Cell Fractionation Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Biotechnology Companies
11.4. Pharmaceutical Companies
11.5. Hospitals & Diagnostic Laboratories
12. Cell Lysis/Cell Fractionation Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Cell Lysis/Cell Fractionation Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Cell Lysis/Cell Fractionation Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies Inc.
16.2. Akadeum Life Sciences Inc.
16.3. Beckman Coulter Inc.
16.4. Becton Dickinson and Company
16.5. Bio-Rad Laboratories Inc.
16.6. BioVision Inc.
16.7. Cell Signaling Technology Inc.
16.8. Claremont BioSolutions LLC
16.9. Covaris LLC
16.10. Danaher Corporation
16.11. Eppendorf AG
16.12. F. Hoffmann-La Roche Ltd.
16.13. Invent Biotechnologies Inc.
16.14. Lonza Group AG
16.15. MagBio Genomics
16.16. Merck KGaA
16.17. Microfluidics International Corporation
16.18. Miltenyi Biotec GmbH
16.19. New England Biolabs Inc.
16.20. Parr Instrument Company
16.21. PerkinElmer Inc.
16.22. pluriSelect GmbH
16.23. Promega Corporation
16.24. QIAGEN N.V.
16.25. Qsonica LLC
16.26. Sartorius AG
16.27. STEMCELL Technologies Inc.
16.28. Takara Bio Inc.
16.29. Thermo Fisher Scientific Inc.
16.30. Zymo Research Corp.
17. Key Experts
List of Figures [21]
List of Tables [347]
For more information about this report visit https://www.researchandmarkets.com/r/cup4r4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.